PSA’s CARRCentritech division is a global leader in designing, manufacturing and marketing of liquid/solid centrifugal separation systems offering innovative and enabling solutions in the manufacturing of pharmaceuticals including vaccines and therapeutics, animal vaccines and specialty chemicals including ink jet ink, cosmetic additives and controlled release drug delivery systems.
The CARR Powerfuge® and Viafuge® Separation Systems with separating forces up 20,000 x G are offered with automatic CIP and SIP to allow for a complete aseptic processing. Optional hazardous duty (Class 1, Div 1) configurations available.
The CARR UniFuge® Separation System, a first of its kind, meets a significant unmet manufacturing need in the biotech industry – a single-use process centrifuge that eliminates the need for expensive cleaning and sterilization requirements and reduces the possibility of contamination. The UniFuge® enables the biopharmaceutical industry to produce the critical medicines we need faster and for significantly less cost.
The Centritech Separation System is the first single-use centrifuge developed for perfusion cell culture processes and cell banking applications, including the emerging stem cell market.